Cargando…
PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review.
The Prostate Specific Antigen (PSA) is the first filter in the diagnosis of prostate cancer. Unfortunately, it is organ-specific but not cancer-specific. In addition, some prostate cancers are not clinically-significant and their diagnosis and treatment may lead to overdiagnosis and overtreatment. F...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mattioli 1885
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823593/ https://www.ncbi.nlm.nih.gov/pubmed/35075069 http://dx.doi.org/10.23750/abm.v92i6.12058 |